Status:

COMPLETED

Hepatitis C Pharmacy-based Strategy for Injectors

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Hepatitis C

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this study is evaluate the acceptability/usage of a newly implemented model of delivery of care, namely a community-pharmacy program, to provide access to medications to treat hepatitis C (...

Detailed Description

Single-arm, prospective observational study of 40 adult persons who inject drugs (PWID) who screen positive for hepatitis C virus (HCV) with a reactive antibody test at community sites who are offered...

Eligibility Criteria

Inclusion

  • \>18 years old
  • Reports injecting drugs with 90 days of screening
  • Positive HCV test documented (screening antibody test or viral load test)
  • Not currently taking medications to treat HCV, and never previously treated with direct-acting antivirals (DAAs) for HCV
  • Willing to undergo evaluation for HCV through a community pharmacy program and work with Patient Navigators
  • Provides release of information (ROI) to access community pharmacy program records and/or other HCV treatment providers

Exclusion

  • People who plan to leave the Seattle area within 6 months
  • Who do not wish to be treated for their HCV infection
  • Who are known to be pregnant
  • Who report impending incarceration that would disrupt clinical care
  • Who are not comfortable reading and speaking English
  • Who report being HIV-positive
  • Who report having end-stage renal disease or require dialysis treatments
  • Who report prior enrolled in (i.e. completed at least the initial intake appointment) the Kelley-Ross pharmacy program for hepatitis C treatment ("One Step Hep C Free")

Key Trial Info

Start Date :

November 5 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04698629

Start Date

November 5 2020

End Date

June 30 2023

Last Update

April 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Washington

Seattle, Washington, United States, 98104